164 related articles for article (PubMed ID: 20463325)
41. Amelioration of experimental autoimmune uveoretinitis (EAU) with an inhibitor of nuclear factor-kappaB (NF-kappaB), pyrrolidine dithiocarbamate.
Kitamei H; Iwabuchi K; Namba K; Yoshida K; Yanagawa Y; Kitaichi N; Kitamura M; Ohno S; Onoé K
J Leukoc Biol; 2006 Jun; 79(6):1193-201. PubMed ID: 16574770
[TBL] [Abstract][Full Text] [Related]
42. Identification of a new epitope of human IRBP that induces autoimmune uveoretinitis in mice of the H-2b haplotype.
Avichezer D; Silver PB; Chan CC; Wiggert B; Caspi RR
Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):127-31. PubMed ID: 10634611
[TBL] [Abstract][Full Text] [Related]
43. Administration of a peptide inhibitor of alpha4-integrin inhibits the development of experimental autoimmune uveitis.
Martín AP; de Moraes LV; Tadokoro CE; Commodaro AG; Urrets-Zavalia E; Rabinovich GA; Urrets-Zavalia J; Rizzo LV; Serra HM
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2056-63. PubMed ID: 15914623
[TBL] [Abstract][Full Text] [Related]
44. Murine experimental autoimmune uveoretinitis induced by interphotoreceptor retinoid-binding protein and Klebsiella pneumoniae 03 lipopolysaccharide (K03-LPS): a relation between H-2 haplotype and EAU induction.
Ando K; Yamamoto JH; Fujino Y; Kato N; Mochizuki M
Graefes Arch Clin Exp Ophthalmol; 1994 Feb; 232(2):127-31. PubMed ID: 8157176
[TBL] [Abstract][Full Text] [Related]
45. The role of costimulatory molecules B7-1 and B7-2 in mice with experimental autoimmune uveoretinitis.
Fukai T; Okada AA; Sakai J; Kezuka T; Keino H; Usui M; Yagita H; Okumura K; Mizuguchi J
Graefes Arch Clin Exp Ophthalmol; 1999 Nov; 237(11):928-33. PubMed ID: 10541904
[TBL] [Abstract][Full Text] [Related]
46. Mice deficient in inducible nitric oxide synthase are susceptible to experimental autoimmune uveoretinitis.
Silver PB; Tarrant TK; Chan CC; Wiggert B; Caspi RR
Invest Ophthalmol Vis Sci; 1999 May; 40(6):1280-4. PubMed ID: 10235566
[TBL] [Abstract][Full Text] [Related]
47. Constitutive retinal CD200 expression regulates resident microglia and activation state of inflammatory cells during experimental autoimmune uveoretinitis.
Broderick C; Hoek RM; Forrester JV; Liversidge J; Sedgwick JD; Dick AD
Am J Pathol; 2002 Nov; 161(5):1669-77. PubMed ID: 12414514
[TBL] [Abstract][Full Text] [Related]
48. Resident and infiltrating cells in the rat iris during the early stages of experimental melanin protein-induced uveitis (EMIU).
McMenamin PG; Crewe J; Kijlstra A
Ocul Immunol Inflamm; 1997 Dec; 5(4):223-33. PubMed ID: 9455739
[TBL] [Abstract][Full Text] [Related]
49. Suppression of experimental uveitis with monoclonal antibodies to ICAM-1 and LFA-1.
Uchio E; Kijima M; Tanaka S; Ohno S
Invest Ophthalmol Vis Sci; 1994 Apr; 35(5):2626-31. PubMed ID: 7909311
[TBL] [Abstract][Full Text] [Related]
50. The role of the ICOS/B7RP-1 T cell costimulatory pathway in murine experimental autoimmune uveoretinitis.
Usui Y; Akiba H; Takeuchi M; Kezuka T; Takeuchi A; Hattori T; Okunuki Y; Yamazaki T; Yagita H; Usui M; Okumura K
Eur J Immunol; 2006 Nov; 36(11):3071-81. PubMed ID: 17039566
[TBL] [Abstract][Full Text] [Related]
51. Cryopexy enhances experimental autoimmune uveoretinitis (EAU) in rats.
de Bara R; Kusuda M; Caspers-Velu L; Sanui H; Chan CC; Kuwabara T; Nussenblatt RB; Gery I
Invest Ophthalmol Vis Sci; 1989 Oct; 30(10):2165-73. PubMed ID: 2793357
[TBL] [Abstract][Full Text] [Related]
52. Genetic control of susceptibility to experimental autoimmune uveoretinitis in the mouse model. Concomitant regulation by MHC and non-MHC genes.
Caspi RR; Grubbs BG; Chan CC; Chader GJ; Wiggert B
J Immunol; 1992 Apr; 148(8):2384-9. PubMed ID: 1560198
[TBL] [Abstract][Full Text] [Related]
53. Dynamic changes of microRNAs in the eye during the development of experimental autoimmune uveoretinitis.
Ishida W; Fukuda K; Higuchi T; Kajisako M; Sakamoto S; Fukushima A
Invest Ophthalmol Vis Sci; 2011 Feb; 52(1):611-7. PubMed ID: 20881307
[TBL] [Abstract][Full Text] [Related]
54. [Participation of sodium iodate in the induction of experimental autoimmune uveoretinitis (EAU)].
Tanaka T
Nippon Ganka Gakkai Zasshi; 1991 Nov; 95(11):1077-84. PubMed ID: 1759647
[TBL] [Abstract][Full Text] [Related]
55. Pathogenic role of retinal microglia in experimental uveoretinitis.
Rao NA; Kimoto T; Zamir E; Giri R; Wang R; Ito S; Pararajasegaram G; Read RW; Wu GS
Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):22-31. PubMed ID: 12506051
[TBL] [Abstract][Full Text] [Related]
56. Bone marrow-derived cells in the central nervous system of a mouse model of amyotrophic lateral sclerosis are associated with blood vessels and express CX(3)CR1.
Lewis CA; Solomon JN; Rossi FM; Krieger C
Glia; 2009 Oct; 57(13):1410-9. PubMed ID: 19243075
[TBL] [Abstract][Full Text] [Related]
57. Role of CX3CR1 receptor in monocyte/macrophage driven neovascularization.
Kumar AH; Martin K; Turner EC; Buneker CK; Dorgham K; Deterre P; Caplice NM
PLoS One; 2013; 8(2):e57230. PubMed ID: 23437346
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of mouse experimental autoimmune uveoretinitis by spectral domain optical coherence tomography.
Harimoto K; Ito M; Karasawa Y; Sakurai Y; Takeuchi M
Br J Ophthalmol; 2014 Jun; 98(6):808-12. PubMed ID: 24574437
[TBL] [Abstract][Full Text] [Related]
59. CX3CR1-deficiency is associated with increased severity of disease in experimental autoimmune uveitis.
Dagkalis A; Wallace C; Hing B; Liversidge J; Crane IJ
Immunology; 2009 Sep; 128(1):25-33. PubMed ID: 19689733
[TBL] [Abstract][Full Text] [Related]
60. IFN-β inhibits the increased expression of IL-9 during experimental autoimmune uveoretinitis.
Yang Y; Du L; Sun M; Kijlstra A; Yang P
PLoS One; 2012; 7(10):e48566. PubMed ID: 23119059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]